NCT07223554

Brief Summary

This research study aims to evaluate the feasibility and acceptability of a web-based, self-guided, disease-specific self-management program tailored to individual health status profiles for patients with painful chronic pancreatitis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 29, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 3, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

December 4, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 28, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 28, 2026

Completed
Last Updated

May 1, 2026

Status Verified

April 1, 2026

Enrollment Period

5 months

First QC Date

October 29, 2025

Last Update Submit

April 29, 2026

Conditions

Keywords

Behavioral interventionSelf-managementPain

Outcome Measures

Primary Outcomes (2)

  • Proportion of enrolled participants that log in at least once during weeks 1-4 and at least once to the recommended modules during weeks 5-12.

    This number is used to determine adherence to the intervention.

    12 weeks

  • Proportion of participants with an average item score of ≥4 out of 5 on the Acceptability of Healthcare Interventions Questionnaire

    This is a validated 8-item questionnaire that assesses acceptability using a 5-point Likert scale rated 1-5.

    12 weeks

Secondary Outcomes (7)

  • Proportion of participants approached that enroll in the study.

    Approximately 1 year (during recruitment period)

  • Proportion of enrolled participants that log in at least once during the 12-week program

    12 weeks

  • Proportion of enrolled participants that log in at least once a week during weeks 1-4 and at least once a week to the recommended modules during weeks 5-12.

    12 weeks

  • Number of logins per participant during the 12-week intervention

    12 weeks

  • Proportion of fully completed questionnaires by the total number given to participants

    12 weeks

  • +2 more secondary outcomes

Study Arms (1)

Web-based self-management program

EXPERIMENTAL

Participants will be assigned to a web-based, self-management program that has been adapted to chronic pancreatitis. Participants will participate in this program for 12 weeks.

Behavioral: Web-based self--management program

Interventions

Participants in this study will be granted access to the adapted website after participants complete baseline questionnaires. All participants will be encouraged to engage with all the sections of the website. From week 1 to 4, participants will receive a single standardized guidance to complete one module a week on generic pain modules. From weeks 5 to 12, participants will receive weekly tailored messaging that will direct participants to specific modules based on individual survey scores from the baseline assessments.

Web-based self-management program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Physician diagnosis of chronic pancreatitis.
  • Abdominal pain for ≥ 3 months and of intensity rated at least 4 or higher on a 0-10 Numeric Rating Scale at least once in the last month.
  • Access to an Internet-connected device (e.g. computer or phone).

You may not qualify if:

  • Unable to speak or read English as the web-based program is currently in English language only.
  • Incarcerated individuals.
  • Currently receiving chemotherapy.
  • Suspected or diagnosed pancreatic cancer.
  • Currently receiving psychotherapy or cognitive behavioral therapy.
  • Serious visual difficulties that would limit completing the web-based program.
  • Substantial cognitive impairment or mental illness that would prevent providing informed consent and completion of questionnaires.
  • Any other condition, which in the opinion of the investigator would impede compliance or hinder the completion of the study.
  • Actively enrolled in another clinical trial for chronic pancreatitis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

MeSH Terms

Conditions

Pancreatitis, ChronicPain

Condition Hierarchy (Ancestors)

PancreatitisPancreatic DiseasesDigestive System DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Jorge Machicado, MD, MPH

    University of Michigan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Associate Professor

Study Record Dates

First Submitted

October 29, 2025

First Posted

November 3, 2025

Study Start

December 4, 2025

Primary Completion

April 28, 2026

Study Completion

April 28, 2026

Last Updated

May 1, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations